Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Milestone IO Approvals

Jedd Wolchok

MD, PhD

🏢Weill Cornell Medicine, NewYork-Presbyterian🌐USA

Meyer Director, Sandra and Edward Meyer Cancer Center

160
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Jedd Wolchok led the CheckMate-067 trial establishing combination ipilimumab plus nivolumab as a standard for advanced melanoma with durable survival in a substantial fraction of patients. He now directs the Meyer Cancer Center at Weill Cornell. He is a leader in combination checkpoint therapy.

Share:

🧪Research Fields 研究领域

CheckMate-067
ipilimumab plus nivolumab
melanoma immunotherapy
combination IO
checkpoint approvals

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Jedd Wolchok 的研究动态

Follow Jedd Wolchok's research updates

留下邮箱,当我们发布与 Jedd Wolchok(Weill Cornell Medicine, NewYork-Presbyterian)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment